Soluble urokinase plasminogen activator receptor (suPAR) predicts hospital readmissions and all-cause mortality in patients admitted with asthma
K. Håkansson (Copenhagen, Denmark), L. J. H. Rasmussen (Copenhagen, Denmark), N. S. Godtfredsen (Copenhagen, Denmark), O. Djurhuus Tupper (Copenhagen, Denmark), J. Eugen-Olsen (Copenhagen, Denmark), T. Kallemose (Copenhagen, Denmark), O. Andersen (Copenhagen, Denmark), K. Marsaa (Copenhagen, Denmark), C. S. Ulrik (Copenhagen, Denmark)
Source: International Congress 2019 – Long-term lung function: from early birth to adulthood
Session: Long-term lung function: from early birth to adulthood
Session type: Oral Presentation
Number: 1941
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Håkansson (Copenhagen, Denmark), L. J. H. Rasmussen (Copenhagen, Denmark), N. S. Godtfredsen (Copenhagen, Denmark), O. Djurhuus Tupper (Copenhagen, Denmark), J. Eugen-Olsen (Copenhagen, Denmark), T. Kallemose (Copenhagen, Denmark), O. Andersen (Copenhagen, Denmark), K. Marsaa (Copenhagen, Denmark), C. S. Ulrik (Copenhagen, Denmark). Soluble urokinase plasminogen activator receptor (suPAR) predicts hospital readmissions and all-cause mortality in patients admitted with asthma. 1941
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: